HK Stock MarketDetailed Quotes
02415 MEDSCI
- 0.860
- -0.020-2.27%
Trading Oct 16 13:21 CST
522.17MMarket Cap11.03P/E (TTM)
0.890High0.860Low28.50KVolume0.870Open0.880Pre Close24.69KTurnover0.01%Turnover Ratio8.60P/E (Static)607.17MShares6.11052wk High0.42P/B522.17MFloat Cap0.61052wk Low--Dividend TTM607.17MShs Float13.460Historical High--Dividend LFY3.41%Amplitude0.610Historical Low0.866Avg Price250Lot Size--Div YieldTTM--Div Yield LFY
MEDSCI Key Stats
All
YOY
| (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||
| Earning before tax | -101.86%-240K | 162.78%60.45M | 111.99%12.89M | 34.52%-96.29M | ---107.45M | -543.31%-147.06M | 77.18%33.17M | --18.72M |
| Profit adjustment | ||||||||
| Interest (income) - adjustment | -71.57%-10.32M | -48.10%-15.37M | -40.11%-6.01M | -114.22%-10.38M | ---4.29M | -229.82%-4.85M | -48.08%-1.47M | ---992K |
| Impairment and provisions: | -9.27%519K | 437.33%13.62M | -82.68%572K | -61.04%2.53M | --3.3M | 1,182.84%6.5M | 71.86%507K | --295K |
| -Impairment of trade receivables (reversal) | 83.75%-52K | -121.88%-35K | -321.05%-320K | -76.23%160K | ---76K | 286.78%673K | 17.57%174K | --148K |
| -Other impairments and provisions | -35.99%571K | 475.02%13.65M | -73.59%892K | -59.29%2.37M | --3.38M | 1,651.05%5.83M | 126.53%333K | --147K |
| Revaluation surplus: | 46.82%-7.39M | ---6.97M | ---13.9M | ---- | ---- | 19,239.56%190.63M | -107.93%-996K | ---479K |
| -Other fair value changes | 46.82%-7.39M | ---6.97M | ---13.9M | ---- | ---- | 19,239.56%190.63M | -107.93%-996K | ---479K |
| Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---836K | ---- | ---- |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---836K | ---- | ---- |
| Depreciation and amortization: | -0.90%3.96M | -0.33%8.35M | -8.44%3.99M | -1.16%8.38M | --4.36M | 19.30%8.48M | 9.61%7.11M | --6.48M |
| -Amortization of intangible assets | 285.71%432K | 738.46%654K | --112K | --78K | ---- | ---- | ---- | ---- |
| Financial expense | -42.48%88K | -22.69%276K | -0.65%153K | 31.73%357K | --154K | -35.63%271K | -7.47%421K | --455K |
| Special items | 418.34%16.53M | -106.41%-7.42M | -96.64%3.19M | 1,319.31%115.69M | --94.82M | --8.15M | ---- | ---- |
| Operating profit before the change of operating capital | 258.09%3.14M | 160.93%52.93M | 109.65%878K | -66.90%20.29M | ---9.1M | 58.21%61.29M | 58.23%38.74M | --24.48M |
| Change of operating capital | ||||||||
| Accounts receivable (increase)decrease | 11.68%9.22M | 136.52%2.99M | 831.60%8.25M | 36.18%-8.19M | --886K | -794.63%-12.83M | 85.63%-1.43M | ---9.98M |
| Accounts payable increase (decrease) | 219.10%1.95M | 254.44%8.07M | -219.81%-1.64M | -127.13%-5.23M | --1.37M | -45.47%19.27M | 30.85%35.33M | --27M |
| prepayments (increase)decrease | -573.03%-22.53M | 88.41%-623K | 81.71%-3.35M | -66.26%-5.38M | ---18.31M | -225.35%-3.23M | 78.00%-994K | ---4.52M |
| Special items for working capital changes | 212.43%8.4M | -129.15%-37.5M | 42.10%-7.47M | 52.71%-16.36M | ---12.91M | -219.76%-34.6M | -31.27%-10.82M | ---8.24M |
| Cash from business operations | 105.47%182K | 274.01%25.88M | 91.26%-3.33M | -149.74%-14.87M | ---38.06M | -50.85%29.89M | 111.60%60.82M | --28.75M |
| Other taxs | -40.51%-4.51M | 66.39%-3.21M | 64.66%-3.21M | -465.66%-9.55M | ---9.08M | 142.87%2.61M | -1,692.06%-6.09M | ---340K |
| Interest received - operating | 71.57%10.32M | 48.10%15.37M | 40.11%6.01M | 114.22%10.38M | --4.29M | 229.82%4.85M | 48.08%1.47M | --992K |
| Net cash from operations | 1,242.75%5.99M | 370.87%38.04M | 98.78%-524K | -137.59%-14.04M | ---42.85M | -33.54%37.35M | 91.18%56.2M | --29.4M |
| Cash flow from investment activities | ||||||||
| Loan receivable (increase) decrease | ---- | --250K | --250K | ---- | ---- | ---- | --1.05M | ---- |
| Decrease in deposits (increase) | ---280.29M | ---4.25M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | --16K | ---- | ---- | --31K | ---- | ---- | ---- | ---- |
| Purchase of fixed assets | -18.82%-202K | 65.13%-181K | 41.38%-170K | 41.62%-519K | ---290K | 19.98%-889K | -513.81%-1.11M | ---181K |
| Purchase of intangible assets | 61.29%-144K | -7.60%-1.77M | ---372K | ---1.65M | ---- | ---- | ---- | ---- |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---1.15M | ---- | ---- |
| Recovery of cash from investments | --217.67M | --299.32M | ---- | ---- | ---- | ---- | --31.48M | ---- |
| Cash on investment | 38.54%-231.01M | ---788.35M | ---375.87M | ---- | ---- | ---- | ---- | ---30M |
| Net cash from investment operations | 21.85%-293.96M | -23,105.53%-494.97M | -129,611.72%-376.16M | -4.87%-2.13M | ---290K | -106.47%-2.03M | 204.09%31.41M | ---30.18M |
| Net cash before financing | 23.55%-287.97M | -2,724.96%-456.94M | -773.24%-376.69M | -145.80%-16.18M | ---43.14M | -59.69%35.32M | 11,275.26%87.61M | ---784K |
| Cash flow from financing activities | ||||||||
| Issuing shares | ---- | --519.86M | --519.86M | ---- | ---- | --297.1M | ---- | ---- |
| Absorb investment income | ---- | ---- | ---- | --100K | --100K | ---- | --100M | ---- |
| Issuance expenses and redemption of securities expenses | ---171K | ---42.01M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | --1.38M | ---- | ---- | ---- | ---- | ---3.88M | ---- | ---- |
| Net cash from financing operations | -100.30%-1.54M | 6,365.67%470.93M | 11,979.48%516.4M | -102.63%-7.52M | ---4.35M | 206.75%285.56M | 1,629.59%93.09M | ---6.09M |
| Effect of rate | -88.99%2.33M | -43.12%15.33M | 10.42%21.17M | 1,562.56%26.96M | --19.17M | -1,362.70%-1.84M | -250.00%-126K | --84K |
| Net Cash | -307.22%-289.51M | 159.05%13.99M | 394.23%139.71M | -107.38%-23.69M | ---47.48M | 77.57%320.87M | 2,730.35%180.71M | ---6.87M |
| Begining period cash | 4.89%628.59M | 0.55%599.27M | 0.55%599.27M | 115.18%596M | --596M | 187.34%276.97M | -6.58%96.39M | --103.18M |
| Cash at the end | -55.09%341.4M | 4.89%628.59M | 33.90%760.15M | 0.55%599.27M | --567.69M | 115.18%596M | 187.34%276.97M | --96.39M |
| Cash balance analysis | ||||||||
| Cash and bank balance | -55.09%341.4M | 4.89%628.59M | --760.15M | --599.27M | ---- | ---- | ---- | ---- |
| Cash and cash equivalent balance | -55.09%341.4M | 4.89%628.59M | --760.15M | --599.27M | ---- | ---- | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |
| Auditor | -- | Ernst & Young | -- | Ernst & Young | -- | Ernst & Young | Ernst & Young | Ernst & Young |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
% Chg
No Data